Eluxadoline for treating irritable bowel syndrome with diarrhoea - guidance (TA471) | Document summary | Evidence search | NICE

Eluxadoline for treating irritable bowel syndrome with diarrhoea - guidance (TA471)

Source:: National Institute for Health and Care Excellence - NICE
Publication date:: 30 August 2017

Abstract

Evidence-based recommendations on eluxadoline (Truberzi) for treating irritable bowel syndrome with diarrhoea in adults.

Guidance development process

How we develop NICE technology appraisal guidance

Next review: August 2020